Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy CONMED Corporation (CNMD) stocks in Canada

Learn how to easily invest in CONMED Corporation stocks.

CONMED Corporation is a medical devices business based in the US. CONMED Corporation stocks (CNMD.US) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $136.39 – a decrease of 4.53% over the previous week. CONMED Corporation employs 3,400 staff and has a trailing 12-month revenue of around $989.5 million.

How to buy shares in CONMED Corporation

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – CNMD – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

CONMED Corporation stock price (NYSE:CNMD)

Use our graph to track the performance of CNMD stocks over time.

CONMED Corporation shares at a glance

Information last updated 2022-01-16.
Latest market close$130.35
52-week range$105.50 - $158.88
50-day moving average $141.77
200-day moving average $136.71
Wall St. target price$160.60
PE ratio 69.8915
Dividend yield $0.8 (0.59%)
Earnings per share (TTM) $1.94

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
Wealthsimple Trade
Finder Rating:
3.9 / 5
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
3.8 / 5
$4.99 - $9.99
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
4.1 / 5
Min. $1.00, Max. 0.5%
Stocks, Bonds, Options, ETFs, Currencies, Futures
CIBC Investor's Edge
Finder Rating:
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Finder Rating:
4.2 / 5
$4.95 - $9.95
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get a $50 bonus when you open a new RRSP, TFSA or RESP and start pre-authorized contributions of $200+/month. Valid until March 1, 2022.

Compare up to 4 providers

Online stock trading

Is it a good time to buy CONMED Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

CONMED Corporation price performance over time

Historical closes compared with the close of $130.35 from 2022-01-19

1 week (2022-01-13) -4.53%
1 month (2021-12-21) -4.20%
3 months (2021-10-21) -10.12%
6 months (2021-07-21) -3.01%
1 year (2021-01-21) 8.63%
2 years (2020-01-21) 19.52%
3 years (2019-01-18) 95.60%
5 years (2017-01-20) 199.93%

Is CONMED Corporation under- or over-valued?

Valuing CONMED Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of CONMED Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

CONMED Corporation's P/E ratio

CONMED Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 70x. In other words, CONMED Corporation shares trade at around 70x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

CONMED Corporation's PEG ratio

CONMED Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 5.29. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into CONMED Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

CONMED Corporation's EBITDA

CONMED Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $166.4 million.

The EBITDA is a measure of a CONMED Corporation's overall financial performance and is widely used to measure a its profitability.

CONMED Corporation financials

Revenue TTM $989.5 million
Operating margin TTM 10.08%
Gross profit TTM $477 million
Return on assets TTM 3.57%
Return on equity TTM 8.65%
Profit margin 6.29%
Book value $25.85
Market capitalisation $4 billion

TTM: trailing 12 months

CONMED Corporation share dividends


Dividend payout ratio: 26.85% of net profits

Recently CONMED Corporation has paid out, on average, around 26.85% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.59% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), CONMED Corporation shareholders could enjoy a 0.59% return on their shares, in the form of dividend payments. In CONMED Corporation's case, that would currently equate to about $0.8 per share.

While CONMED Corporation's payout ratio might seem fairly standard, it's worth remembering that CONMED Corporation may be investing much of the rest of its net profits in future growth.

CONMED Corporation's most recent dividend payout was on 4 January 2022. The latest dividend was paid out to all shareholders who bought their shares by 13 December 2021 (the "ex-dividend date").

Have CONMED Corporation's shares ever split?

CONMED Corporation's shares were split on a 3:2 basis on 9 September 2001. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your CONMED Corporation shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for CONMED Corporation shares which in turn could have impacted CONMED Corporation's share price.

CONMED Corporation share price volatility

Over the last 12 months, CONMED Corporation's shares have ranged in value from as little as $105.4981 up to $158.8772. A popular way to gauge a stock's volatility is its "beta".

CNMD.US volatility(beta: 1.57)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while CONMED Corporation's is 1.5722. This would suggest that CONMED Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

CONMED Corporation overview

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures worldwide. It offers orthopedic surgery products, including sports medicine products comprising powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, and metal and bioabsorbable implants, as well as related disposable products and fluid management systems; powered surgical instruments for use in bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries; sports biologics and tissue products; and surgical visualization products. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida. .

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site